EXTON, Pa., June 4, 2012 /PRNewswire/ -- ViroPharma Incorporated (NASDAQ: VPHM) today announced the initiation of a Phase 2 program to evaluate maribavir for the treatment of cytomegalovirus

SAN DIEGO, May 31, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc.

LOS ANGELES, May 25, 2012 /PRNewswire/ -- The Lin Law Firm, A Professional Law Corporation, announces that a class action has been filed on behalf of investors who purchased the securities of

EXTON, Pa., May 22, 2012 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Charles Rowland, vice president and chief financial officer of ViroPharma, will present at

EXTON, Pa., May 2, 2012 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Charles Rowland, vice president and chief financial officer of ViroPharma,